Press articles about CML patient being denied access by NICE to drug he needs

This CML (Chronic Myeloid Leukaemia) patient is facing similar issues as our MDS patients with azacitidine, as NICE’s preliminary decision is NOT TO recommend 2 drugs that can treat this condition. Continue reading…

A technique which may eventually remove the need for matched bone marrow transplants has been used in humans for the first time.
Continue reading…